PCN20 Comparison of Nab-paclitaxel PLUS Gemcitabine Versus FOLFIRINOX in First LINE Treatment of Metastatic Pancreatic Cancer in China: A Cost-Effectiveness Analysis
Abstract
Authors
L. Wang X. Zhang S. Qu C. Ye J. Cui Y. Liu
L. Wang X. Zhang S. Qu C. Ye J. Cui Y. Liu
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now